M. Martín

1.2k total citations
56 papers, 731 citations indexed

About

M. Martín is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M. Martín has authored 56 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in M. Martín's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Head and Neck Cancer Studies (8 papers). M. Martín is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Head and Neck Cancer Studies (8 papers). M. Martín collaborates with scholars based in Spain, United States and France. M. Martín's co-authors include Mario López, L. Cerezo, Alicia Marín, D. Büchser, Laura M. Fernández, Felipe Couñago, A. Hervás, Fernando López‐Campos, Inmaculada Asensio Muñoz and Juan Carlos García Pérez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

M. Martín

51 papers receiving 713 citations

Peers

Countries citing papers authored by M. Martín

Since Specialization

Citations

This map shows the geographic impact of M. Martín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Martín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Martín more than expected).

Fields of papers citing papers by M. Martín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Martín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Martín. The network helps show where M. Martín may publish in the future.

Co-authorship network of co-authors of M. Martín

This figure shows the co-authorship network connecting the top 25 collaborators of M. Martín. A scholar is included among the top collaborators of M. Martín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Martín. M. Martín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the effectiveness of a nutritional support programme in patients with diarrhoea secondary to abdominal and/or pelvic radiotherapy, whether or not associated with other cancer treatments, in radiation oncology departments 2025 ·Nutrición Hospitalaria ·M. Martín, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Current landscape of gastrointestinal radiation oncology in Spain: a multicenter real-life survey and comparison with key clinical guidelines 2024 ·Reports of Practical Oncology & Radiotherapy ·(unknown), (unknown), (unknown), (unknown), Fernando López‐Campos, (unknown), M. Martín, V. Morillo, (unknown)	0
3	A Cross-Cultural Examination of Parents’ Book Selection & Shared Reading Practices in Spain and Israel 2023 ·Early Education and Development ·(unknown), M. Martín, Dorit Aram	1
4	Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal Cancer: Where Do We Stand? 2023 ·Oncology ·(unknown), M. Martín, Juan Carlos García‐Ruiz, (unknown), Diego Rincón, (unknown), Juan P. Fusco, (unknown), (unknown), (unknown), Fernando López‐Campos, Felipe Couñago	0
5	Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer 2022 ·Oncology ·(unknown), Fernando López‐Campos, M. Martín, (unknown), (unknown), Felipe Couñago, (unknown)	11
6	Targeted Therapy Moves to Earlier Stages of Non-Small-Cell Lung Cancer: Emerging Evidence, Controversies and Future Challenges 2021 ·Future Oncology ·Xabier Mielgo-Rubio, M. Martín, Jordi Remón, Oliver Higuera, Virginia Calvo, J.R. Jarabo, Esther Conde, J. Luna, Mariano Provencio, Javier de Castro, Fernando López‐Ríos, Florentino Hernándo, Felipe Couñago	16
7	Management of Resectable Stage III-N2 Non-Small-Cell Lung Cancer (NSCLC) in the Age of Immunotherapy 2021 ·Cancers ·Xabier Mielgo-Rubio, (unknown), (unknown), J. Luna, (unknown), Laura Mezquita, M. Martín, Felipe Couñago	16
8	272P Outcomes of patients (pts) who had received prior platinum (PP) therapy in the phase III EMBRACA trial of talazoparib (TALA) vs physician’s choice of chemotherapy (PCT) in patients with germline BRCA1/2 mutated (gBRCA1/2mut) advanced breast cancer (ABC) 2021 ·Annals of Oncology ·M. Martín, H. S. Rugo, Sara A. Hurvitz, Johannes Ettl, Henri Roché, KH Lee, Annabel Goodwin, Tiziana Usari, Silvana Lanzalone, (unknown), JL Blum, Jennifer K. Litton	1
9	GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma 2021 ·World Journal of Clinical Oncology ·J. Luna, (unknown), (unknown), (unknown), M. Martín, (unknown), (unknown), Aurora Rodríguez, (unknown), (unknown), Mauricio A. Moreno, Felipe Couñago	2
10	Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers 2020 ·Cancers ·Xabier Mielgo-Rubio, Virginia Calvo, J. Luna, Jordi Remón, M. Martín, Pedro Berraondo, J.R. Jarabo, Oliver Higuera, Esther Conde, Javier de Castro, Mariano Provencio, Florentino Hernándo, Fernando López‐Ríos, Felipe Couñago	9
11	Metformin and statins: a possible role in high-risk prostate cancer 2020 ·Reports of Practical Oncology & Radiotherapy ·(unknown), A. Hervás, M. Martín, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Fernando López‐Campos	5
12	Watch and wait approach in rectal cancer: Current controversies and future directions 2020 ·World Journal of Gastroenterology ·Fernando López‐Campos, M. Martín, (unknown), Juan Carlos García Pérez, Javier Díe Trill, (unknown), (unknown), (unknown), (unknown), (unknown), A. Hervás, Felipe Couñago	81
13	Products based on olive oil, betaine, and xylitol in the post-radiotherapy xerostomia 2016 ·Reports of Practical Oncology & Radiotherapy ·M. Martín, Alicia Marín, Mario López, (unknown), (unknown), D. Büchser, L. Cerezo	12
14	Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer 2015 ·Clinical & Translational Oncology ·M. Martín, (unknown), L. Cerezo, Jacinto Garcı́a, (unknown), Justina Prada, Alicia Marín, Carlos Gamallo	9
15	Experience of the Institut Gustave-Roussy in Alternating Radiotherapy and Chemotherapy Schedules as Induction Treatment in Limited Small-Cell Lung Cancer 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·T. Le Chevalier, R. Arriagada, François Thomas, P Baldeyrou, Pierre Ruffiè, Hubert de Crémoux, M. Martín, (unknown), (unknown), Michèle Tarayre, H Sancho-Garnier, A. Grop	0
16	Bystander effects and radiotherapy 2014 ·Reports of Practical Oncology & Radiotherapy ·Alicia Marín, M. Martín, (unknown), (unknown), Mario López, Laura M. Fernández, D. Büchser, L. Cerezo	143
17	Oropharyngeal cancer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain 2013 ·Clinical & Translational Oncology ·L. Cerezo, Alejandro de la Torre, A. Hervás, (unknown), (unknown), (unknown), (unknown), M. Martín	7
18	Gastrointestinal toxicity associated to radiation therapy 2010 ·Clinical & Translational Oncology ·(unknown), M. Martín, L. Cerezo, (unknown), (unknown)	20
19	Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study 2006 ·Radiotherapy and Oncology ·Enis Özyar, Uğur Selek, (unknown), Ömer Uzel, Yavuz Anacak, (unknown), (unknown), Fadime Akman, Suzanne L. Wolden, (unknown), Robert C. Miller, Mahmut Özsahin, Ufuk Abacıoğlu, M. Martín, Murat Çaloğlu, Luciano Scandolaro, (unknown), İ. Lale Atahan	62
20	Paclitaxel plus vinorelbine: An active regimen in metastatic breast cancer patients with prior anthracycline exposure 2000 ·Annals of Oncology ·M. Martín, Aňa Lluch, Antonio Casado, Iciar Garcı́a Carbonero, (unknown), Carmen Esteban, Amelia Insa, Rosario Alfonso, J Garcı́a-Conde, Eduardo Díaz‐Rubio	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact